C - Reactive Protein (CRP) is a blood test that measures the level of CRP, a protein produced by the liver in response to inflammation.Its a nonspecific marker of inflammation, meaning it can be elevated in various conditions, including infections, autoimmune diseases, and heart disease. While CRP does not diagnose a specific condition, it can help monitor disease activity, assess the risk of heart attack or stroke, and guide treatment decisions.

LIVER FUNCTION TESTS ARE A GROUP OF BLOOD TESTS THAT EVALUATE THE HEALTH AND FUNCTION OF YOUR LIVER. THEY MEASURE LEVELS OF VARIOUS ENZYMES, PROTEINS, AND SUBSTANCES PRODUCED BY THE LIVER. ABNORMAL RESULTS CAN INDICATE LIVER DAMAGE, INFLAMMATION, OR DISEASE. COMMON LIVER FUNCTION TESTS INCLUDE ALT, AST, ALKALINE PHOSPHATASE, BILIRUBIN, AND ALBUMIN. THESE TESTS HELP DIAGNOSE CONDITIONS LIKE HEPATITIS, CIRRHOSIS, AND FATTY LIVER DISEASE, AS WELL AS MONITOR LIVER HEALTH IN PEOPLE WITH CHRONIC CONDITIONS.

The Complete Blood Count Advanced (CBC Advanced) test provides a comprehensive assessment of blood health by measuring various parameters of red blood cells, white blood cells, and platelets. It goes beyond the standard CBC by including additional markers like reticulocyte count, immature granulocyte count, and platelet indices, offering a deeper understanding of blood cell production, function, and potential abnormalities. This advanced test is valuable in diagnosing a wide range of conditions, including anemia, infections, blood clotting disorders, and certain types of cancer.

Kidney Function Tests (KFTs) evaluate how well your kidneys are filtering waste products from your blood. These tests typically include measurements of creatinine, blood urea nitrogen (BUN), and electrolytes. By assessing these values, healthcare providers can identify potential kidney problems, monitor kidney disease progression, and evaluate the effectiveness of treatment. KFTs are crucial for individuals with diabetes, high blood pressure, or a family history of kidney disease.

NLR (NEUTROPHIL LYMPHOCYTE RATIO) IS A MEANINGFUL PARAMETER FOR PROGNOSIS AND RISK STRATIFICATION IN PATIENTS INFECTED WITH COVID-19. IT IS AN INDEPENDENT RISK FACTOR FOR CRITICAL ILLNESS IN PATIENTS WITH COVID-19.

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IS THE CAUSATIVE AGENT OF CORONAVIRUS DISEASE 2019 (COVID-19). IT IS AN INFECTIOUS DISEASE FIRST IDENTIFIED IN 2019 IN WUHAN, THE CAPITAL OF CHINAS HUBEI PROVINCE. IT HAS SPREAD GLOBALLY, RESULTING IN THE 2019 2020 CORONAVIRUS PANDEMIC. COMMON SYMPTOMS INCLUDE FEVER, COUGH, SHORTNESS OF BREATH, MUSCLE PAIN, SPUTUM PRODUCTION, DIARRHOEA, SORE THROAT, ABDOMINAL PAIN, AND LOSS OF SMELL OR TASTE. MAJORITY OF CASES RESULT IN MILD SYMPTOMS WHILE IN A FEW CASES IT MAY PROGRESS TO PNEUMONIA AND MULTI-ORGAN FAILURE. THE VIRUS IS MAINLY SPREAD DURING CLOSE CONTACT VIA RESPIRATORY DROPLETS PRODUCED WHEN PEOPLE COUGH OR SNEEZE.